{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:11:45Z","timestamp":1783426305318,"version":"3.54.6"},"reference-count":55,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To assess the association between gentamicin exposure in the neonatal period and hearing in school age.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>This study included children exposed to a high-dose (6 mg\/kg) gentamicin regimen as neonates (2004\u20132012), invited for follow-up at school age, and a healthy age-matched control group. We assessed hearing with pure tone audiometry including the extended high-frequency (EHF) range. Outcomes were average hearing thresholds in the midfrequencies (0.5\u20134 kHz) and the EHFs (9\u201316 kHz). The measures of gentamicin exposure were cumulative dose and highest trough plasma concentration. We used linear regression models to assess the impact of gentamicin exposure, and other peri- and postnatal morbidities, on hearing thresholds.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>A total of 219 gentamicin-exposed and 33 healthy-control children were included in the audiological analysis. In the gentamicin cohort, 39 (17%) had a birth weight &amp;lt;1500 g. Median cumulative doses and trough plasma concentrations were 30 (interquartile range 24\u201342) mg\/kg and 1.0 (interquartile range 0.7\u20131.2) mg\/L, respectively. Median hearing thresholds for the midfrequencies and the EHFs were 2.5 (0 to 6.3) dB hearing level and \u22121.7 (\u22125.0 to 5.0) dB hearing level, both of which were within the normal range. In an adjusted analysis, increasing hearing thresholds were associated with lower birth weight and postnatal middle-ear disease but not level of gentamicin exposure. After adjusting for birth weight, there was no difference in hearing threshold between the gentamicin-exposed cohort and healthy controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Exposure to a high-dose gentamicin regimen in the neonatal period was not associated with an increase in hearing thresholds in schoolchildren being able to complete audiometry.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2019-2373","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T13:29:18Z","timestamp":1578490158000},"source":"Crossref","is-referenced-by-count":7,"title":["Hearing in Schoolchildren After Neonatal Exposure to a High-Dose Gentamicin Regimen"],"prefix":"10.1542","volume":"145","author":[{"given":"Dagny","family":"Hemmingsen","sequence":"first","affiliation":[{"name":"Departments of Otorhinolaryngology and Head and Neck Surgery and"},{"name":"Paediatric Research Group, Faculty of Health Sciences, Univeristy of Troms\u00f8-Arctic University of Norway, Troms\u00f8, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Mikalsen","sequence":"additional","affiliation":[{"name":"Departments of Otorhinolaryngology and Head and Neck Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Rydland","family":"Hansen","sequence":"additional","affiliation":[{"name":"Departments of Otorhinolaryngology and Head and Neck Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Widding","family":"Fjalstad","sequence":"additional","affiliation":[{"name":"Paediatric Research Group, Faculty of Health Sciences, Univeristy of Troms\u00f8-Arctic University of Norway, Troms\u00f8, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Christian","family":"Stenklev","sequence":"additional","affiliation":[{"name":"Ear-Nose-Throat Unit, Ishavsklinikken, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Klingenberg","sequence":"additional","affiliation":[{"name":"Paediatrics and Adolescence Medicine, University Hospital of North Norway, Troms\u00f8, Norway;"},{"name":"Paediatric Research Group, Faculty of Health Sciences, Univeristy of Troms\u00f8-Arctic University of Norway, Troms\u00f8, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"issue":"1","key":"2021120819562367600_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0000000000000906","article-title":"Early-onset sepsis and antibiotic exposure in term infants: a nationwide population-based study in Norway","volume":"35","author":"Fjalstad","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"2021120819562367600_B2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0033-1361933","article-title":"Medication use in the neonatal intensive care unit","volume":"31","author":"Hsieh","year":"2014","journal-title":"Am J Perinatol"},{"key":"2021120819562367600_B3","first-page":"CD005091","article-title":"One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates","volume":"12","author":"Rao","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2021120819562367600_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02004-17","article-title":"Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations","volume":"62","author":"van Donge","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2021120819562367600_B5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14787210.2014.878648","article-title":"Aminoglycoside toxicity in neonates: something to worry about?","volume":"12","author":"Kent","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"2021120819562367600_B6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/pbc.24631","article-title":"Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides","volume":"60","author":"Chen","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"2021120819562367600_B7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1651-2227.2007.00398.x","article-title":"Prevalence and independent risk factors for hearing loss in NICU infants","volume":"96","author":"Hille","year":"2007","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021120819562367600_B8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1542\/peds.2007-2333","article-title":"Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs","volume":"120","author":"American Academy of Pediatrics, Joint Committee on Infant Hearing","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"2021120819562367600_B9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mpd.2003.mpd037","article-title":"Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss","volume":"142","author":"de Hoog","year":"2003","journal-title":"J Pediatr"},{"issue":"1","key":"2021120819562367600_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000244391","article-title":"Risk factors of sensorineural hearing loss in preterm infants","volume":"71","author":"Borradori","year":"1997","journal-title":"Biol Neonate"},{"issue":"7","key":"2021120819562367600_B11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ijporl.2011.04.007","article-title":"Risk factors associated with hearing loss in infants: an analysis of 5282 referred neonates","volume":"75","author":"Bielecki","year":"2011","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"11","key":"2021120819562367600_B12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.ijporl.2015.09.004","article-title":"Effect of sepsis and systemic inflammatory response syndrome on neonatal hearing screening outcomes following gentamicin exposure","volume":"79","author":"Cross","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"2021120819562367600_B13","doi-asserted-by":"crossref","first-page":"F141","DOI":"10.1136\/fn.82.2.F141","article-title":"Sensorineural hearing loss and prematurity","volume":"82","author":"Marlow","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2021120819562367600_B14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpeds.2018.07.101","article-title":"Evaluation of gentamicin exposure in the neonatal intensive care unit and hearing function at discharge","volume":"203","author":"Puia-Dumitrescu","year":"2018","journal-title":"J Pediatr"},{"issue":"2","key":"2021120819562367600_B15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000324857","article-title":"Are gentamicin and\/or vancomycin associated with ototoxicity in the neonate? A retrospective audit","volume":"100","author":"Vella-Brincat","year":"2011","journal-title":"Neonatology"},{"issue":"6","key":"2021120819562367600_B16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/165.6.1026","article-title":"High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity","volume":"165","author":"Fausti","year":"1992","journal-title":"J Infect Dis"},{"issue":"3","key":"2021120819562367600_B17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00003446-199406000-00004","article-title":"High-frequency audiometric monitoring strategies for early detection of ototoxicity","volume":"15","author":"Fausti","year":"1994","journal-title":"Ear Hear"},{"issue":"2","key":"2021120819562367600_B18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"2","key":"2021120819562367600_B19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/14992027.2010.524253","article-title":"Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: a study using extended high-frequency audiometry and distortion product otoacoustic emissions","volume":"50","author":"Al-Malky","year":"2011","journal-title":"Int J Audiol"},{"issue":"4","key":"2021120819562367600_B20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00431-013-2194-1","article-title":"High-dose gentamicin in newborn infants: is it safe?","volume":"173","author":"Fjalstad","year":"2013","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2021120819562367600_B21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clp.2016.01.006","article-title":"Bilirubin-induced audiologic injury in preterm infants","volume":"43","author":"Olds","year":"2016","journal-title":"Clin Perinatol"},{"issue":"4","key":"2021120819562367600_B22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/apa.14141","article-title":"Phototherapy is commonly used for neonatal jaundice but greater control is needed to avoid toxicity in the most vulnerable infants","volume":"107","author":"Mreihil","year":"2018","journal-title":"Acta Paediatr"},{"key":"2021120819562367600_B23","unstructured":"International Organization for Standardization . ISO 389-5:2006. Acoustics \u2014 Reference zero for the calibration of audiometric equipment \u2014 Part 5: Reference equivalent threshold sound pressure levels for pure tones in the frequency range 8 kHz to 16 kHz. Available at: https:\/\/www.iso.org\/standard\/40535.html. Accessed November 22, 2019"},{"key":"2021120819562367600_B24","unstructured":"International Organization for Standardization . ISO 389-1:2017. Acoustics \u2014 Reference zero for the calibration of audiometric equipment \u2014 Part 1: Reference equivalent threshold sound pressure levels for pure tones and supra-aural earphones. Available at: https:\/\/www.iso.org\/standard\/69855.html. Accessed November 22, 2019"},{"key":"2021120819562367600_B25","unstructured":"International Organization for Standardization . ISO 8253-1:2010. Acoustics \u2014 Audiometric test methods \u2014 Part 1: Pure-tone air and bone conduction audiometry. Available at: https:\/\/www.iso.org\/standard\/43601.html. Accessed November 22, 2019"},{"key":"2021120819562367600_B26","first-page":"1","volume-title":"Global Burden of Hearing Loss in the Year 2000","author":"Mathers","year":"2000"},{"issue":"1","key":"2021120819562367600_B27","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4081\/audiores.2012.e8","article-title":"A report of extended high frequency audiometry thresholds in school-age children with no hearing complaints","volume":"2","author":"Anastasio","year":"2012","journal-title":"Audiology Res"},{"issue":"1","key":"2021120819562367600_B28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00405-011-1616-9","article-title":"Pure-tone auditory threshold in school children","volume":"269","author":"M\u00fcller","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"9","key":"2021120819562367600_B29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ijporl.2010.05.024","article-title":"Risk factors for sensorineural hearing loss in NICU infants compared to normal hearing NICU controls","volume":"74","author":"Coenraad","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"8","key":"2021120819562367600_B30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/14992027.2014.893375","article-title":"Extended high-frequency (9-20 kHz) audiometry reference thresholds in 645 healthy subjects","volume":"53","author":"Rodr\u00edguez Valiente","year":"2014","journal-title":"Int J Audiol"},{"issue":"7","key":"2021120819562367600_B31","doi-asserted-by":"crossref","first-page":"e0158806","DOI":"10.1371\/journal.pone.0158806","article-title":"Gentamicin exposure and sensorineural hearing loss in preterm infants","volume":"11","author":"Fuchs","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"2021120819562367600_B32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.63.3.443","article-title":"Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study","volume":"63","author":"Finitzo-Hieber","year":"1979","journal-title":"Pediatrics"},{"issue":"10","key":"2021120819562367600_B33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"2021120819562367600_B34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijporl.2010.05.011","article-title":"Cisplatinum ototoxicity in children, long-term follow up","volume":"74","author":"Al-Khatib","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1\u20132","key":"2021120819562367600_B35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-5876(95)01232-X","article-title":"Delayed post-neonatal intensive care unit hearing disturbance","volume":"34","author":"Kawashiro","year":"1996","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"2021120819562367600_B36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1542\/peds.78.3.417","article-title":"Unexpected hearing loss in high-risk infants","volume":"78","author":"Nield","year":"1986","journal-title":"Pediatrics"},{"key":"2021120819562367600_B37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fncel.2017.00308","article-title":"Aminoglycoside-induced cochleotoxicity: a review","volume":"11","author":"Jiang","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"2021120819562367600_B38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.stemcr.2014.01.008","article-title":"Lgr5-positive supporting cells generate new hair cells in the postnatal cochlea","volume":"2","author":"Bramhall","year":"2014","journal-title":"Stem Cell Reports"},{"issue":"3","key":"2021120819562367600_B39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-5876(93)90230-Z","article-title":"Serial measurements of transient evoked otoacoustic emissions (TEOAEs) in healthy newborns and in newborns with perinatal infection","volume":"27","author":"Zorowka","year":"1993","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1","key":"2021120819562367600_B40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3476(85)80485-6","article-title":"Prospective controlled evaluation of auditory function in neonates given netilmicin or amikacin","volume":"106","author":"Finitzo-Hieber","year":"1985","journal-title":"J Pediatr"},{"key":"2021120819562367600_B41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijporl.2016.12.029","article-title":"Prevalence and independent risk factors for hearing impairment among very low birth weight infants","volume":"93","author":"Wang","year":"2017","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"2021120819562367600_B42","first-page":"527","article-title":"Newborn and infant hearing loss: detection and intervention. American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999","volume":"103","author":"Erenberg","year":"1999","journal-title":"Pediatrics"},{"issue":"6","key":"2021120819562367600_B43","doi-asserted-by":"crossref","first-page":"F462","DOI":"10.1136\/adc.2007.124214","article-title":"Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology","volume":"93","author":"Cristobal","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"2021120819562367600_B44","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/14992020802215862","article-title":"Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review","volume":"47","author":"Bindu","year":"2008","journal-title":"Int J Audiol"},{"issue":"5","key":"2021120819562367600_B45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.otohns.2010.01.030","article-title":"Genetic mutations and aminoglycoside-induced ototoxicity in neonates","volume":"142","author":"Johnson","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"2021120819562367600_B46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMc0806396","article-title":"Prevalence of mitochondrial 1555A\u2013&gt;G mutation in European children","volume":"360","author":"Bitner-Glindzicz","year":"2009","journal-title":"N Engl J Med"},{"key":"2021120819562367600_B47","doi-asserted-by":"crossref","unstructured":"Mahood\u2008R. \u2008Pharmacogenetics to avoid loss of hearing. ISRCTN Registry number 1370489. Available at: 10.1186\/ISRCTN13704894. Accessed November 22, 2019","DOI":"10.1186\/ISRCTN13704894"},{"issue":"2","key":"2021120819562367600_B48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/21695717.2016.1151124","article-title":"The frequency of the m.1555A&gt;G (MTRNR1) variant in UK patients with suspected mitochondrial deafness","volume":"14","author":"Kullar","year":"2016","journal-title":"Hear Balance Commun"},{"issue":"2","key":"2021120819562367600_B49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/jmedgenet-2014-102753","article-title":"Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis","volume":"52","author":"Jing","year":"2015","journal-title":"J Med Genet"},{"issue":"1","key":"2021120819562367600_B50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijporl.2014.10.025","article-title":"Risk factors for sensorineural hearing loss in pediatric chronic otitis media","volume":"79","author":"Yehudai","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"9","key":"2021120819562367600_B51","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ijporl.2013.06.025","article-title":"The risk of hearing loss in a population with a high prevalence of chronic suppurative otitis media","volume":"77","author":"Jensen","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1","key":"2021120819562367600_B52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003446-199602000-00001","article-title":"High frequency hearing loss associated with otitis media","volume":"17","author":"Hunter","year":"1996","journal-title":"Ear Hear"},{"issue":"4","key":"2021120819562367600_B53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpeds.2013.06.012","article-title":"Factors associated with permanent hearing impairment in infants treated with therapeutic hypothermia","volume":"163","author":"Smit","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"2021120819562367600_B54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejpn.2018.10.002","article-title":"Hearing impairment and hypoxia ischaemic encephalopathy: incidence and associated factors","volume":"23","author":"Fitzgerald","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"2021120819562367600_B55","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1542\/peds.102.5.1161","article-title":"Language of early- and later-identified children with hearing loss","volume":"102","author":"Yoshinaga-Itano","year":"1998","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2373\/1078356\/peds_20192373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2373\/1078356\/peds_20192373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T10:19:45Z","timestamp":1665397185000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/145\/2\/e20192373\/68235\/Hearing-in-Schoolchildren-After-Neonatal-Exposure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,1]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-2373","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"article-number":"e20192373"}}